Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Physicians' Desk Reference. Problems and possible improvements

J S Cohen1, P A Insel

  • 1Department of Psychiatry, University of California, San Diego, School of Medicine, La Jolla, USA.

Archives of Internal Medicine
|July 8, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The incremental risk of fragility fractures in aging men.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Same author

De novo variants in KLF7 are a potential novel cause of developmental delay/intellectual disability, neuromuscular and psychiatric symptoms.

Clinical genetics·2017
Same author

Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance.

Clinical genetics·2017
Same author

Further evidence that de novo missense and truncating variants in ZBTB18 cause intellectual disability with variable features.

Clinical genetics·2016
Same author

Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.

Clinical genetics·2014
Same author

The role of trial tracking on rats' successive delayed matching-to-sample modality performance.

Behavioural processes·2014

The Physicians' Desk Reference (PDR) provides drug information but has limitations. Its content is supplied and funded by drug makers, reflecting negotiated agreements with regulators.

Area of Science:

  • Pharmacology
  • Medical Information Dissemination

Background:

  • The Physicians' Desk Reference (PDR) is a key drug information resource for US physicians and patients.
  • The PDR's content is sourced directly from pharmaceutical manufacturers.

Purpose of the Study:

  • To critically evaluate the shortcomings of the PDR as a drug information source.
  • To examine the influence of pharmaceutical manufacturers and regulatory bodies on PDR content.

Main Methods:

  • Analysis of the PDR's content sourcing and funding model.
  • Review of the relationship between PDR information, drug package inserts, and regulatory approval processes.

Main Results:

  • PDR content is identical to drug package inserts, which are provided by pharmaceutical companies.

Related Experiment Videos

  • The information presented in the PDR is a result of negotiations between commercial entities and the Food and Drug Administration (FDA).

    • Conclusions:

    • The PDR's content is inherently influenced by pharmaceutical manufacturers.
    • The PDR represents a negotiated agreement between industry and regulators, potentially impacting its objectivity.